Advertisement

Clinical spectrum of Lyme disease

  • Jesus Alberto Cardenas-de la Garza
  • Estephania De la Cruz-Valadez
  • Jorge Ocampo-Candiani
  • Oliverio WelshEmail author
Review

Abstract

Lyme disease (borreliosis) is one of the most common vector-borne diseases worldwide. Its incidence and geographic expansion has been steadily increasing in the last decades. Lyme disease is caused by Borrelia burgdorferi sensu lato, a heterogeneous group of which three genospecies have been systematically associated to Lyme disease: B. burgdorferi sensu stricto Borrelia afzelii and Borrelia garinii. Geographical distribution and clinical manifestations vary according to the species involved. Lyme disease clinical manifestations may be divided into three stages. Early localized stage is characterized by erythema migrans in the tick bite site. Early disseminated stage may present multiple erythema migrans lesions, borrelial lymphocytoma, lyme neuroborreliosis, carditis, or arthritis. The late disseminated stage manifests with acordermatitis chronica atrophicans, lyme arthritis, and neurological symptoms. Diagnosis is challenging due to the varied clinical manifestations it may present and usually involves a two-step serological approach. In the current review, we present a thorough revision of the clinical manifestations Lyme disease may present. Additionally, history, microbiology, diagnosis, post-treatment Lyme disease syndrome, treatment, and prognosis are discussed.

Keywords

Lyme disease Borrelia burgdorferi Tick-borne diseases Ixodes Erythema migrans Lyme neuroborreliosis 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants performed by any of the authors.

Informed consent

Informed consent was obtained for iconographies.

References

  1. 1.
    Dammin GJ (1989) Erythema migrans: a chronicle. Rev Infect Dis 11(1):142–151CrossRefGoogle Scholar
  2. 2.
    Herrera Lorenzo O, Infante Ferrer J, Ramírez Reyes C, Lavastida Hernández H (2012) Enfermedad de Lyme: historia, microbiología, epizootiología y epidemiología. Rev Cubana Hig Epidemiol 50:231–244Google Scholar
  3. 3.
    Steere AC, Malawista SE, Snydman DR, Shope RE, Andiman WA, Ross MR et al (1977) Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum 20:7–17CrossRefGoogle Scholar
  4. 4.
    Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwaldt E, Davis JP (1982) Lyme disease-a tick-borne spirochetosis? Science 216:1317–1319CrossRefGoogle Scholar
  5. 5.
    Mead PS (2015) Epidemiology of Lyme disease. Infect Dis Clin N Am 29:187–210CrossRefGoogle Scholar
  6. 6.
    Gordillo G, Torres J, Solorzano F, Cedillo-Rivera R, Tapia-Conyer R, Munoz O (1999) Serologic evidences suggesting the presence of Borrelia burgdorferi infection in Mexico. Arch Med Res 30:64–68CrossRefGoogle Scholar
  7. 7.
    Gordillo-Pérez G, Torres J, Solórzano-Santos F, Garduño-Bautista V, Tapia-Conyer R, Muñoz O (2003) Estudio seroepidemiológico de borreliosis de Lyme en la Ciudad de México y el noreste de la República Mexicana. Salud Publica Mex 45:351–355CrossRefGoogle Scholar
  8. 8.
    Gordillo-Perez G, Vargas M, Solorzano-Santos F, Rivera A, Polaco OJ, Alvarado L et al (2009) Demonstration of Borrelia burgdorferi sensu stricto infection in ticks from the northeast of Mexico. Clin Microbiol Infect 15:496–498CrossRefGoogle Scholar
  9. 9.
    Fang LQ, Liu K, Li XL, Liang S, Yang Y, Yao HW et al (2015) Emerging tick-borne infections in mainland China: an increasing public health threat. Lancet Infect Dis 15:1467–1479CrossRefGoogle Scholar
  10. 10.
    Lopes FA, Rezende J, Silva D, Alves FCG, Oliveira CE, Costa IPD (2017) Molecular evidence of Borrelia burgdorferi sensu lato in patients in Brazilian central-western region. Rev Bras Reumatol Eng Ed 57:641–645CrossRefGoogle Scholar
  11. 11.
    Rudenko N, Golovchenko M, Grubhoffer L, Oliver JH Jr (2011) Updates on Borrelia burgdorferi sensu lato complex with respect to public health. Ticks Tick Borne Dis 2:123–128CrossRefGoogle Scholar
  12. 12.
    Stanek G, Reiter M (2011) The expanding Lyme Borrelia complex--clinical significance of genomic species? Clin Microbiol Infect 17:487–493CrossRefGoogle Scholar
  13. 13.
    Salkeld DJ, Leonhard S, Girard YA, Hahn N, Mun J, Padgett KA et al (2008) Identifying the reservoir hosts of the Lyme disease spirochete Borrelia burgdorferi in California: the role of the western gray squirrel (Sciurus griseus). Am J Trop Med Hyg 79:535–540CrossRefGoogle Scholar
  14. 14.
    Radolf JD, Caimano MJ, Stevenson B, Hu LT (2012) Of ticks, mice and men: understanding the dual-host lifestyle of Lyme disease spirochaetes. Nat Rev Microbiol 10:87–99CrossRefGoogle Scholar
  15. 15.
    Borchers AT, Keen CL, Huntley AC, Gershwin ME (2015) Lyme disease: a rigorous review of diagnostic criteria and treatment. J Autoinmun 57:82–115CrossRefGoogle Scholar
  16. 16.
    Miraflor AP, Seidel GD, Perry AE, Castanedo-Tardan MP, Guill MA, Yan S (2016) The many masks of cutaneous Lyme disease. J Cutan Pathol 43:32–40CrossRefGoogle Scholar
  17. 17.
    Vasudevan B, Chatterjee M (2013) Lyme borreliosis and skin. Indian J Dermatol 58(3):167–174CrossRefGoogle Scholar
  18. 18.
    Steere AC, Strle F, Wormser GP, Hu LT, Branda JA, Hovius JW, Li X, Mead PS (2016) Lyme borreliosis. Nat Rev Dis Primer 2:16090.  https://doi.org/10.1038/nrdp.2016.90
  19. 19.
    Godar DA, Laniosz V, Wetter DA (2015) Lyme disease update for the general dermatologist. Am J Clin Dermatol 16:5–18CrossRefGoogle Scholar
  20. 20.
    Mullegger RR, Glatz M (2008) Skin manifestations of Lyme borreliosis: diagnosis and management. Am J Clin Dermatol 9:355–368CrossRefGoogle Scholar
  21. 21.
    Lenormand C, Jaulhac B, Debarbieux S, Dupin N, Granel-Brocard F, Adamski H et al (2016) Expanding the clinicopathological spectrum of late cutaneous Lyme borreliosis (acrodermatitis chronica atrophicans [ACA]): a prospective study of 20 culture- and/or polymerase chain reaction (PCR)-documented cases. J Am Acad Dermatol 74:685–692CrossRefGoogle Scholar
  22. 22.
    Bauvin O, Schmutz JL, De Martino S, Busato T, Cribier B, Barbaud A et al (2017) A foot tumour as late cutaneous Lyme borreliosis: a new entity? Br J Dermatol 177(4):1127–1130CrossRefGoogle Scholar
  23. 23.
    Maraspin V, Nahtigal Klevišar M, Ružić-Sabljić E, Lusa L, Strle F (2016) Borrelial Lymphocytoma in adult patients. Clin Infect Dis 63:914–921CrossRefGoogle Scholar
  24. 24.
    Zinchuk AN, Kalyuzhna LD, Pasichna IA (2016) Is localized scleroderma caused by Borrelia burgdorferi? Vector Borne Zoonotic Dis (Larchmont, NY) 16:577–580CrossRefGoogle Scholar
  25. 25.
    Gutierrez-Gomez C, Godinez-Hana AL, Garcia-Hernandez M, Suarez-Roa Mde L, Toussaint-Caire S, Vega-Memije E et al (2014) Lack of IgG antibody seropositivity to Borrelia burgdorferi in patients with Parry-Romberg syndrome and linear morphea en coup de sabre in Mexico. Int J Dermatol 53:947–951CrossRefGoogle Scholar
  26. 26.
    Eisendle K, Grabner T, Kutzner H, Zelger B (2008) Possible role of Borrelia burgdorferi sensu lato infection in lichen sclerosus. Arch Dermatol 144:591–598CrossRefGoogle Scholar
  27. 27.
    Arvikar SL, Steere AC (2015) Diagnosis and treatment of Lyme arthritis. Infect Dis Clin N Am 29:269–280CrossRefGoogle Scholar
  28. 28.
    Robinson ML, Kobayashi T, Higgins Y, Calkins H, Melia MT (2015) Lyme carditis. Infect Dis Clin N Am 29:255–268CrossRefGoogle Scholar
  29. 29.
    Scheffold N, Herkommer B, Kandolf R, May AE (2015) Lyme carditis--diagnosis, treatment and prognosis. Dtsch Arztebl Int 112:202–208Google Scholar
  30. 30.
    Marques AR (2015) Lyme neuroborreliosis. Continuum (Minneapolis, Minn). Neuroinfect Dis 21:1729–1744Google Scholar
  31. 31.
    Halperin JJ (2015) Nervous system Lyme disease. Infect Dis Clin N Am 29(2):241–253CrossRefGoogle Scholar
  32. 32.
    Koedel U, Fingerle V, Pfister HW (2015) Lyme neuroborreliosis-epidemiology, diagnosis and management. Nat Rev Neurol 11:446–456CrossRefGoogle Scholar
  33. 33.
    Ogrinc K, Lusa L, Lotric-Furlan S, Bogovic P, Stupica D, Cerar T et al (2016) Course and outcome of early European Lyme neuroborreliosis (Bannwarth syndrome): clinical and laboratory findings. Clin Infect Dis 63:346–353CrossRefGoogle Scholar
  34. 34.
    Zajkowska J, Garkowski A, Moniuszko A, Czupryna P, Ptaszynska-Sarosiek I, Tarasow E et al (2015) Vasculitis and stroke due to Lyme neuroborreliosis - a review. Infect dis (London, England) 47:1–6Google Scholar
  35. 35.
    Aucott JN (2015) Posttreatment Lyme disease syndrome. Infect Dis Clin N Am 29:309–323CrossRefGoogle Scholar
  36. 36.
    Berende A, ter Hofstede HJ, Vos FJ, van Middendorp H, Vogelaar ML, Tromp M et al (2016) Randomized trial of longer-term therapy for symptoms attributed to Lyme disease. N Engl J Med 374:1209–1220CrossRefGoogle Scholar
  37. 37.
    CDC (1995) MMWR Morbidity and mortality weekly report. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. https://www.cdc.gov/mmwr/preview/mmwrhtml/00042555.htm .Accesed 10 July 2018
  38. 38.
    Stanek G, Fingerle V, Hunfeld KP, Jaulhac B, Kaiser R, Krause A et al (2011) Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect 17:69–79CrossRefGoogle Scholar
  39. 39.
    Shapiro ED (2014) Lyme disease. N Engl J Med 370(18):1724–1731CrossRefGoogle Scholar
  40. 40.
    Mygland A, Ljostad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I (2010) EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol 17:8–16CrossRefGoogle Scholar
  41. 41.
    Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS et al (2006) The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 43:1089–1134CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Jesus Alberto Cardenas-de la Garza
    • 1
  • Estephania De la Cruz-Valadez
    • 1
  • Jorge Ocampo-Candiani
    • 1
  • Oliverio Welsh
    • 1
    Email author
  1. 1.University Hospital “Dr. Jose Eleuterio Gonzalez”, Department of DermatologyUniversidad Autonoma de Nuevo LeonMonterreyMexico

Personalised recommendations